Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer? CyberKnife, IMRT and VMAT in low risk prostate cancer.
Authors: Borowicz D, Skrobała A, Kruszyna-Mochalska M, Malicki J.
Published in: Radiology and Oncology
Publication type: article
Subject areas: Medicine
SJR best quartile: Q2